Literature DB >> 8828627

Recommendations for protein and amino acid intake in phenylketonuric patients.

F Cockburn1, B J Clark.   

Abstract

The methods for the determination of protein requirements are reviewed and the difficulties in achieving the recommendations of the dietary management of phenylketonuria proposed by a Medical Research Council Working Party on Phenylketonuria using currently available low phenylalanine (Phe) protein substitutes and low protein foods are examined. These recommendations are that all infants whose blood Phe concentrations exceed 600 mumol/l in the presence of a normal or low plasma tyrosine and an otherwise normal plasma amino acid profile while receiving a normal protein intake (2-3 g/kg/day), should start a low Phe diet immediately. Infants whose blood Phe concentrations remain persistently between 400 and 600 mumol/l for more than a few days should also start treatment. The diet should contain a protein substitute which is Phe free (or at least very low in Phe) and otherwise nutritionally complete with a composition sufficient to provide 100-120 mg/kg per day of tyrosine and a total amino acid intake of at least 3 g/kg per day in children under 2 years of age. In children over 2 years the intake of amino acids should be maintained at a level of 2 g/kg per day. The protein substitute should be spread as evenly as possible through the 24 h. Blood Phe concentrations should be maintained between 120 and 360 mumol/l. In children aged over 10 years it is suggested that the protein substitute should supply the protein reference nutrient intake + 50%. An upper blood Phe limit of 480 mumol/l rather than 360 mumol/l may be acceptable in school age children. Adults and adolescents should continue treatment with the aim to maintain blood Phe concentrations no higher than 700 mumol/l. During the period before conception and during pregnancy women should aim to have plasma Phe concentrations between 60-250 mumol/l.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828627     DOI: 10.1007/pl00014228

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

2.  Interpretation of the plasma amino acid pattern of low birth weight infants.

Authors:  W C Heird
Journal:  Nutrition       Date:  1989 Mar-Apr       Impact factor: 4.008

3.  Fasting plasma amino acid concentrations in PKU children on two different levels of protein intake.

Authors:  E Kindt; H A Lunde; L R Gjessing; S Halvorsen; S O Lie
Journal:  Acta Paediatr Scand       Date:  1988-01

Review 4.  Rhythmicity of plasma amino acids and relation to dietary intake.

Authors:  R D Feigin; W R Beisel; R W Wannemacher
Journal:  Am J Clin Nutr       Date:  1971-03       Impact factor: 7.045

5.  The relationship between serum urea levels and dietary nitrogen ultilization in young men.

Authors:  V S Taylor; N S Scrimshaw; V R Young
Journal:  Br J Nutr       Date:  1974-09       Impact factor: 3.718

6.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

7.  Effect of high crude fiber intake on transit time and the absorption of nutrients in South African Negro schoolchildren.

Authors:  A R Walker
Journal:  Am J Clin Nutr       Date:  1975-10       Impact factor: 7.045

8.  Nutrient intake of treated infants with phenylketonuria.

Authors:  P B Acosta; E Wenz; M Williamson
Journal:  Am J Clin Nutr       Date:  1977-02       Impact factor: 7.045

9.  Requirements and recommended dietary intakes of protein during infancy.

Authors:  S J Fomon
Journal:  Pediatr Res       Date:  1991-11       Impact factor: 3.756

10.  Persistence of human milk proteins in the breast-fed infant.

Authors:  L A Davidson; B Lönnerdal
Journal:  Acta Paediatr Scand       Date:  1987-09
View more
  6 in total

1.  Dietary protein counting as an alternative way of maintaining metabolic control in phenylketonuria.

Authors:  A L Sweeney; R M Roberts; J M Fletcher
Journal:  JIMD Rep       Date:  2011-09-16

Review 2.  Sapropterin dihydrochloride for phenylketonuria.

Authors:  Usha Rani Somaraju; Marcus Merrin
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

3.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

4.  Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.

Authors:  Christineh N Sarkissian; Tse Siang Kang; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2011-06-29       Impact factor: 4.797

Review 5.  What we know that could influence future treatment of phenylketonuria.

Authors:  C N Sarkissian; A Gámez; C R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-08-03       Impact factor: 4.982

6.  Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.

Authors:  Christineh N Sarkissian; Alejandra Gámez; Lin Wang; Marilyse Charbonneau; Paul Fitzpatrick; Jeffrey F Lemontt; Bin Zhao; Michael Vellard; Sean M Bell; Carroll Henschell; Amy Lambert; Laurie Tsuruda; Raymond C Stevens; Charles R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.